Icosapent Ethyl
Back to searchMolecule Structure
Scientific Name
Icosapent Ethyl
Description of the Drug
Icosapent ethyl is an ethyl ester of eicosapentaenoic acid (EPA) that reduces synthesis and enhances clearance of triglycerides that is used to treat patients with severe hypertriglyceridemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08887
http://www.drugbank.ca/drugs/DB08887
Brand Name(s)
Vascepa
Company Owner(s)
Apotex Inc, Teva Pharmaceuticals Usa, Hikma Pharmaceuticals Usa Inc, Amarin Pharmaceuticals Ireland Ltd, Dr Reddys Laboratories Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL123305 | |
| Human Metabolome Database | HMDB0039530 | |
| DrugBank | DB08887 | |
| PubChem: Thomson Pharma | 14851023 | |
| PubChem | 9831415 | |
| NMRShiftDB | 80004409 | |
| LipidMaps | LMFA07010877 | |
| DrugCentral | 1413 | |
| Metabolights | MTBLC84883 | |
| ChemicalBook | CB1505810 | |
| Guide to Pharmacology | 7441 | |
| rxnorm | ICOSAPENT ETHYL | VASCEPA |
| KEGG Ligand | C16184 | |
| ChEBI | 84883 | |
| ZINC | ZINC000003785276 |
